Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity-Reference-Cited by-同舟云学术

Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity

Published:2014 Issue:4 Volume:6 Page:2321-2327
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Sethi Manish¹²³⁴⁵,Sukumar Rohit¹²³⁴⁵,Karve Shrirang¹²³⁴⁵,Werner Michael E.¹²³⁴⁵,Wang Edina C.¹²³⁴⁵,Moore Dominic T.⁴⁵⁶,Kowalczyk Sonya R.¹²³⁴⁵,Zhang Liangfang⁷⁸⁹¹⁰,Wang Andrew Z.¹²³⁴⁵

Affiliation:

1. Carolina Center for Cancer Nanotechnology Excellence

2. Laboratory of Nano- and Translational Medicine

3. Department of Radiation Oncology

4. Lineberger Comprehensive Cancer Center

5. University of North Carolina-Chapel Hill

6. Chapel Hill, USA

7. Department of Nanoengineering

8. Moores Cancer Center

9. University of California

10. San Diego, USA

Abstract

Nanoparticles’ drug release kinetics can directly affect their therapeutic efficacy and toxicity.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2014/NR/C3NR05961H

Reference33 articles.

1. Nanomedicine

2. Nanoparticle Delivery of Cancer Drugs

3. Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform

4. Nanoparticles in Medicine: Therapeutic Applications and Developments

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies – Spotlight on prostate and colorectal cancer;Experimental and Molecular Pathology;2024-06

2. Developing Superior Amoxicillin Delivery Systems: AI-Driven Optimization of LNPs for H. pylori Treatment;2024-04-23

3. Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells;International Journal of Pharmaceutics;2024-04

4. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02

5. Unveiling Emerging Avenues in Antiviral Research: Navigating Clinical Trials and Regulatory Landscapes;Livestock Diseases and Management;2024